Inhibition of HIV-1 transmission by interferon and 3'-azido-3'-deoxythymidine during de novo infection of promonocytic cells
- PMID: 1699354
- DOI: 10.1016/0042-6822(90)90306-c
Inhibition of HIV-1 transmission by interferon and 3'-azido-3'-deoxythymidine during de novo infection of promonocytic cells
Abstract
HIV-1 infection of promonocytic U937 cells was used to examined induction of IFN-alpha/beta gene expression and to determine the inhibitory effects of IFN-alpha 2 and/or AZT on de novo HIV-1 infection, initiated either by coculture of virus-shedding U9-IIIB cells with uninfected cells or by incubation of U937 cells with virus-containing supernatants. Usually 21-28 days were required to transmit virus to greater than 90% of the cell culture. HIV-1 infection did not stimulate constitutive production of endogenous IFN-alpha 1/alpha 2 or IFN-beta genes, although induction of IFN RNA was observed following coinfection with the paramyxovirus Sendai. Exogenous rIFN-alpha 2 treatment decreased the intracellular accumulation of viral RNA 5- to 20-fold as determined by Northern blot analysis and the extracellular levels of HIV-1 as measured by p24 ELISA antigen capture. The effect was most dramatic at a time coincident with the rapid increase in virus spread through the cell culture (Days 10-18). During the fourth week of infection, HIV-1 multiplication was able to overcome the IFN-induced block in virus spread. AZT was not effective in limiting virus spread in the cocultivation experiments. When U937 cells were infected with virus-containing supernatants from U9-IIIB cells, IFN and AZT acted in combination to limit the number of infected cells and to inhibit intracellular accumulation of viral RNA. These experiments suggest that subtle differences in the mode of virus transmission in monocytic cells may alter the efficacy of combination antiretroviral therapy.
Similar articles
-
Coordinate enhancement of cytokine gene expression in human immunodeficiency virus type 1-infected promonocytic cells.J Virol. 1990 Dec;64(12):6080-9. doi: 10.1128/JVI.64.12.6080-6089.1990. J Virol. 1990. PMID: 2243388 Free PMC article.
-
Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.Science. 1989 May 5;244(4904):575-7. doi: 10.1126/science.2470148. Science. 1989. PMID: 2470148
-
Cell-specific differences in activation of NF-kappa B regulatory elements of human immunodeficiency virus and beta interferon promoters by tumor necrosis factor.J Virol. 1990 Oct;64(10):4726-34. doi: 10.1128/JVI.64.10.4726-4734.1990. J Virol. 1990. PMID: 2204723 Free PMC article.
-
Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells.J Virol. 1991 May;65(5):2245-53. doi: 10.1128/JVI.65.5.2245-2253.1991. J Virol. 1991. PMID: 1901915 Free PMC article.
-
Regulation of cytokine and viral gene expression in monocytes infected with the human immunodeficiency virus.Pathobiology. 1991;59(4):209-13. doi: 10.1159/000163647. Pathobiology. 1991. PMID: 1883515 Review.
Cited by
-
Induction of monocytic differentiation and NF-kappa B-like activities by human immunodeficiency virus 1 infection of myelomonoblastic cells.J Exp Med. 1992 Mar 1;175(3):751-63. doi: 10.1084/jem.175.3.751. J Exp Med. 1992. PMID: 1740663 Free PMC article.
-
Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop.Mol Cell Biol. 1993 Oct;13(10):6231-40. doi: 10.1128/mcb.13.10.6231-6240.1993. Mol Cell Biol. 1993. PMID: 8413223 Free PMC article.
-
Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors.Microbiol Rev. 1995 Sep;59(3):481-505. doi: 10.1128/mr.59.3.481-505.1995. Microbiol Rev. 1995. PMID: 7565415 Free PMC article. Review.